PT  - JOURNAL ARTICLE
AU  - Roux, Jonathan
AU  - Massonnaud, Clément
AU  - Colizza, Vittoria
AU  - Cauchemez, Simon
AU  - Crépey, Pascal
TI  - Impact of national and regional lockdowns on COVID-19 epidemic waves: Application to the 2020 spring wave in France
AID  - 10.1101/2021.04.21.21255876
DP  - 2021 Jan 01
TA  - medRxiv
PG  - 2021.04.21.21255876
4099  - http://medrxiv.org/content/early/2021/06/16/2021.04.21.21255876.short
4100  - http://medrxiv.org/content/early/2021/06/16/2021.04.21.21255876.full
AB  - Several countries have implemented lockdowns to control their COVID-19 epidemic. However, questions like “where” and “when” still require answers. We assessed the impact of national and regional lockdowns considering the French first epidemic wave of COVID-19 as a case study. In a regional lockdown scenario aimed at preventing intensive care units (ICU) saturation, almost all French regions would have had to implement a lockdown within 10 days and 96% of ICU capacities would have been used. For slowly growing epidemics, with a lower reproduction number, the expected delays between regional lockdowns increases. However, the public health costs associated with these delays tend to grow exponentially with time. In a quickly growing pandemic wave, defining the timing of lockdowns at a regional rather than national level delays by a few days the implementation of a nationwide lockdown but leads to substantially higher morbidity, mortality and stress on the healthcare system.Competing Interest StatementThe authors have declared no competing interest.Funding StatementThis work was supported by the French national research agency (ANR), through the SPHINx (Spread of Pathogens on Healthcare Institutions Networks) project [grant number SPHINX-17-CE36-0008-01].Author DeclarationsI confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.YesThe details of the IRB/oversight body that provided approval or exemption for the research described are given below:Not applicableAll necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived.YesI understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).YesI have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.YesThe data and code underlying this article will be shared on reasonable request to the corresponding author.